BiotechTube
Home/Vivoryon Therapeutics/Marcus Irsfeld
MI

Marcus Irsfeld

Chief Financial Officer

Vivoryon Therapeutics

Therapeutic Areas

Renal DiseasesFibrotic DisordersInflammatory Diseases

Vivoryon Therapeutics Pipeline

DrugIndicationPhase
varoglutamstatDiabetic Kidney DiseasePhase 2

Leadership Team at Vivoryon Therapeutics

FW
Frank Weber, MD
Chief Executive Officer / Chief Medical Officer, Executive Director
View full Vivoryon Therapeutics profile